03.02.12
Prometrika has selected Medidata Solutions as a strategic partner to increase sponsor access to its range of clinical research services. Prometrika joined Medidata’s Partner Program and has committed to attain Rave accreditation for electronic data capture (EDC) and clinical data management (CDM).
Prometrika has a strong focus on biostatistics and data management, in addition to preparing FDA submissions and managing Phase I-IV trials across a range of therapeutic areas. Medidata’s Rave is a standards-based approach to structured data, which allows for conversions of Rave-centric data into datasets for statistical analysis.
“Medidata clearly understands the business and operational challenges faced by our customer base, new and established biotech companies that are working on some of the most innovative research in the world,” said Dr. Miganush Stepanians, president and chief executive officer of Prometrika. “We chose Medidata as a partner not only for its experience and expertise across the clinical development process, but also for its ability to help us continue to provide the most leading-edge technologies to our sponsor customers.”
Prometrika has a strong focus on biostatistics and data management, in addition to preparing FDA submissions and managing Phase I-IV trials across a range of therapeutic areas. Medidata’s Rave is a standards-based approach to structured data, which allows for conversions of Rave-centric data into datasets for statistical analysis.
“Medidata clearly understands the business and operational challenges faced by our customer base, new and established biotech companies that are working on some of the most innovative research in the world,” said Dr. Miganush Stepanians, president and chief executive officer of Prometrika. “We chose Medidata as a partner not only for its experience and expertise across the clinical development process, but also for its ability to help us continue to provide the most leading-edge technologies to our sponsor customers.”
